166 related articles for article (PubMed ID: 11279947)
1. Fluoxetine for migraine prophylaxis: a double-blind trial.
d'Amato CC; Pizza V; Marmolo T; Giordano E; Alfano V; Nasta A
Headache; 1999; 39(10):716-9. PubMed ID: 11279947
[TBL] [Abstract][Full Text] [Related]
2. S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study.
Steiner TJ; Ahmed F; Findley LJ; MacGregor EA; Wilkinson M
Cephalalgia; 1998 Jun; 18(5):283-6. PubMed ID: 9673809
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine prophylaxis of migraine.
Adly C; Straumanis J; Chesson A
Headache; 1992 Feb; 32(2):101-4. PubMed ID: 1551787
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors for migraine prophylaxis.
Landy S; McGinnis J; Curlin D; Laizure SC
Headache; 1999 Jan; 39(1):28-32. PubMed ID: 15613191
[TBL] [Abstract][Full Text] [Related]
5. [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
Amelin AV; Skoromets AA; Korenko LA; Tumelevich BCh; Gonchar MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(8):20-3. PubMed ID: 10983362
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluoxetine on habituation of pattern reversal visually evoked potentials in migraine prophylaxis.
Ozkul Y; Bozlar S
Headache; 2002; 42(7):582-7. PubMed ID: 12482209
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents.
Gherpelli JL; Esposito SB
Arq Neuropsiquiatr; 2005 Sep; 63(3A):559-63. PubMed ID: 16172700
[TBL] [Abstract][Full Text] [Related]
8. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
9. Double-blind trial of fluoxetine: chronic daily headache and migraine.
Saper JR; Silberstein SD; Lake AE; Winters ME
Headache; 1994 Oct; 34(9):497-502. PubMed ID: 8002320
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluoxetine and placebo in the treatment of obesity.
Fernández-Soto ML; González-Jiménez A; Barredo-Acedo F; Luna del Castillo JD; Escobar-Jiménez F
Ann Nutr Metab; 1995; 39(3):159-63. PubMed ID: 7486842
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
12. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
AFFINITY Trial Collaboration
Lancet Neurol; 2020 Aug; 19(8):651-660. PubMed ID: 32702334
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine: a randomized clinical trial in the maintenance of weight loss.
Goldstein DJ; Rampey AH; Dornseif BE; Levine LR; Potvin JH; Fludzinski LA
Obes Res; 1993 Mar; 1(2):92-8. PubMed ID: 16350565
[TBL] [Abstract][Full Text] [Related]
16. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
Dodick DW; Silberstein SD; Bigal ME; Yeung PP; Goadsby PJ; Blankenbiller T; Grozinski-Wolff M; Yang R; Ma Y; Aycardi E
JAMA; 2018 May; 319(19):1999-2008. PubMed ID: 29800211
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
EFFECTS Trial Collaboration
Lancet Neurol; 2020 Aug; 19(8):661-669. PubMed ID: 32702335
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
Bidabadi E; Mashouf M
Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
[TBL] [Abstract][Full Text] [Related]
19. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
20. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study.
Krymchantowski AV; Silva MT; Barbosa JS; Alves LA
Headache; 2002 Jun; 42(6):510-4. PubMed ID: 12167139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
